24-hydroxycholesterol has been researched along with Brain Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ando, HK; During, MJ; Farnaby, W; Fujimoto, S; Hasegawa, S; Ishi, T; Koike, T; Kondo, S; Kuroita, T; Miyamoto, M; Nishi, T; Ohori, M; Sunahara, E; Watanabe, E; Watanabe, S; Yano, J; Yoshikawa, M | 1 |
Sodero, AO | 1 |
Björkhem, I; Diczfalusy, U; Hillert, J; Leoni, V; Masterman, T; Mousavi, FS; Wahlund, LO; Wretlind, B | 1 |
Björkhem, I | 1 |
2 review(s) available for 24-hydroxycholesterol and Brain Disorders
Article | Year |
---|---|
24S-hydroxycholesterol: Cellular effects and variations in brain diseases.
Topics: Animals; Brain; Brain Diseases; Humans; Hydroxycholesterols | 2021 |
Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Diseases; Cholesterol; Cholesterol 24-Hydroxylase; Homeostasis; Humans; Hydroxycholesterols; Infant; Rats; Steroid Hydroxylases | 2006 |
2 other study(ies) available for 24-hydroxycholesterol and Brain Disorders
Article | Year |
---|---|
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice.
Topics: Amyloid beta-Protein Precursor; Animals; Brain; Brain Diseases; Cholesterol 24-Hydroxylase; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Drug Development; Female; Humans; Hydroxycholesterols; Longevity; Mice; Mice, Knockout; Mice, Transgenic; Mutant Proteins; Piperidines; Presenilin-1; Pyridines; Recombinant Proteins | 2020 |
Diagnostic use of cerebral and extracerebral oxysterols.
Topics: Adult; Aged; Brain Diseases; Female; Humans; Hydroxycholesterols; Male; Middle Aged | 2004 |